A cohort of New Haven Public Schools (NHPS) students will begin cancer and vaccine research this fall at the newly opened laboratory facilities at 101 College St. — thanks to a suite of “BioCity” ...

SHANGHAI, April 9, 2024 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a ...

BioCity Biopharma’s selective endothelin receptor type A (ETA) antagonist has reduced excess proteins in the urine of patients with diabetic kidney disease (DKD), hitting a primary endpoint of a phase ...

BioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with the latter’s Keytruda (pembrolizumab) in a global Phase I/II trial for ...

WUXI, China, Aug. 7, 2023 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a ...

Fifteen high school juniors from Hillhouse, Wilbur Cross, and Career have been selected to join cancer researchers and vaccine developers this fall in bringing to life a long-awaited College Street ...

BioCity, a pioneering life science incubator and business collective, today announced an investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures.

SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration ...

SHANGHAI, July 8, 2024 /PRNewswire/ -- BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reduction in the 2 ...

BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN. Working in partnership, the Oxford Academic Health Science Network and ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When BioCity Nottingham, the UK’s biggest biomedical business incubator, opened just over five years ago, ...